microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma
Cuiling Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Wing C. Chan(Ontario Institute for Cancer Research), Roberto Piva(University of Turin), Karen Dybkær(Aalborg University Hospital), Cynthia M. Lachel(University of Nebraska Medical Center), Dennis D. Weisenburger(University of Nebraska Medical Center), Timothy W. McKeithan(Palmetto Hematology Oncology), Sharathkumar Bhagavathi(University of Nebraska Medical Center), Megan S. Lim(Memorial Sloan Kettering Cancer Center), Elisa Pellegrino(Scuola Superiore Sant'Anna), Timothy C. Greiner(University of Nebraska Medical Center), Javeed Iqbal(University of Nebraska Medical Center), Elisa Spaccarotella(University of Turin), Patricia Aoun(University of Nebraska Medical Center), Julie Teruya‐Feldstein(Memorial Sloan Kettering Cancer Center), Xiaozhou Hu(University of Nebraska Medical Center), Antonella Barreca(University of Turin), Yulei Shen(University of Nebraska Medical Center), Sherrie L. Perkins(University of Utah), Magdalena Julia Dabrowska(Aalborg University Hospital), Can Küçük(Dokuz Eylül University), Chun-Sun Jiang(University of Nebraska Medical Center), Giorgio Inghirami(Cornell University)
Cited by 90
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k